Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
35 hedge funds and large institutions have $575K invested in Nymox Pharmaceutical Corp in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
33% more call options, than puts
Call options by funds: $4K | Put options by funds: $3K
30% more capital invested
Capital invested by funds: $444K → $575K (+$131K)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
5% less funds holding
Funds holding: 37 → 35 (-2)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Corrigan Financial
Middletown,
Rhode Island
|
+$123K |
| 2 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
+$32.5K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$21K |
| 4 |
Millennium Management
New York
|
+$19.5K |
| 5 |
BlackRock
New York
|
+$1.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$12.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.7K |
| 3 |
Jane Street
New York
|
-$8.12K |
| 4 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$6.43K |
| 5 |
Renaissance Technologies
New York
|
-$5.45K |
NYMX Hedge Fund Activity: Q1 2023 in Review
35 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2023, worth a combined $575K — up 30% from $444K a quarter earlier.
Fund positioning in NYMX was balanced in Q1 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 8 trimmed.
The largest buyer was Corrigan Financial, opening a new position worth an estimated $123K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $12.1K.
- 35 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2023, down from 37 in Q4 2022.
- Funds reported $575K of Nymox Pharmaceutical Corp stock for Q1 2023, up 30% quarter-over-quarter.
- 5 funds opened new Nymox Pharmaceutical Corp positions in Q1 2023 and 5 closed out, a net change of 0 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2023 was Corrigan Financial, an estimated $123K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2023 was Federation des caisses Desjardins du Quebec, an estimated $12.1K sold.
Based on aggregated 13F filings for Q1 2023.